"Thyroxine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
| Descriptor ID |
D013974
|
| MeSH Number(s) |
D06.472.931.812 D12.125.072.050.767
|
| Concept/Terms |
Thyroxine- Thyroxine
- T4 Thyroid Hormone
- Thyroid Hormone, T4
- Thyroxin
- O-(4-Hydroxy-3,5-diiodophenyl) 3,5-diiodo-L-tyrosine
- L-3,5,3',5'-Tetraiodothyronine
- Levothyroxine
- L-Thyroxine
- L Thyroxine
- 3,5,3',5'-Tetraiodothyronine
- O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodotyrosine
Levothyroxin Deladande- Levothyroxin Deladande
- Deladande, Levothyroxin
- Levothyroxin Delalande
- Delalande, Levothyroxin
|
Below are MeSH descriptors whose meaning is more general than "Thyroxine".
Below are MeSH descriptors whose meaning is more specific than "Thyroxine".
This graph shows the total number of publications written about "Thyroxine" by people in this website by year, and whether "Thyroxine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1995 | 1 | 5 | 6 |
| 1996 | 0 | 2 | 2 |
| 1997 | 1 | 3 | 4 |
| 1998 | 1 | 4 | 5 |
| 1999 | 0 | 3 | 3 |
| 2000 | 2 | 7 | 9 |
| 2001 | 0 | 4 | 4 |
| 2002 | 1 | 10 | 11 |
| 2003 | 0 | 5 | 5 |
| 2004 | 0 | 2 | 2 |
| 2005 | 1 | 5 | 6 |
| 2006 | 2 | 3 | 5 |
| 2007 | 1 | 3 | 4 |
| 2008 | 1 | 3 | 4 |
| 2009 | 2 | 3 | 5 |
| 2010 | 3 | 4 | 7 |
| 2011 | 2 | 4 | 6 |
| 2012 | 0 | 4 | 4 |
| 2013 | 3 | 4 | 7 |
| 2014 | 1 | 3 | 4 |
| 2015 | 5 | 3 | 8 |
| 2016 | 2 | 2 | 4 |
| 2017 | 2 | 2 | 4 |
| 2018 | 1 | 4 | 5 |
| 2019 | 3 | 3 | 6 |
| 2020 | 6 | 3 | 9 |
| 2021 | 2 | 3 | 5 |
| 2022 | 3 | 6 | 9 |
| 2023 | 5 | 3 | 8 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Thyroxine" by people in Profiles.
-
A Cross-Sectional Analysis of Cardiovascular and Bone Health Care Utilization During Treatment With Thyroid Hormone. J Clin Endocrinol Metab. 2024 Feb 20; 109(3):e1143-e1150.
-
Demographic, Healthcare Access, and Dietary Factors Associated With Thyroid Hormone Treatments for Hypothyroidism. J Clin Endocrinol Metab. 2023 Nov 17; 108(12):e1614-e1623.
-
Sustained Pituitary T3 Production Explains the T4-mediated TSH Feedback Mechanism. Endocrinology. 2023 11 02; 164(12).
-
Emerging Therapies in Hypothyroidism. Annu Rev Med. 2024 Jan 29; 75:307-319.
-
The Effects of Patient Characteristics on the Management of Subclinical Hypothyroidism: A Survey of Faculty and Trainees. Endocr Pract. 2023 Oct; 29(10):787-793.
-
Levothyroxine Treatment Adequacy and Formulation Changes in Patients with Hypothyroidism: A Retrospective Study of Real-World Data from the United States. Thyroid. 2023 08; 33(8):940-949.
-
Are We Restoring Thyroid Hormone Signaling in Levothyroxine-Treated Patients With Residual Symptoms of Hypothyroidism? Endocr Pract. 2023 Jul; 29(7):581-588.
-
Serum Thyrotropin and Triiodothyronine Levels in Levothyroxine-treated Patients. J Clin Endocrinol Metab. 2023 05 17; 108(6):e258-e266.
-
Iodotyrosines Are Biomarkers for Preclinical Stages of Iodine-Deficient Hypothyroidism in Dehal1-Knockout Mice. Thyroid. 2023 06; 33(6):752-761.
-
T3 levels and thyroid hormone signaling. Front Endocrinol (Lausanne). 2022; 13:1044691.